Navigation Links
Researcher awarded $1.8 million grant to study gender differences in antidepressant effects
Date:8/15/2013

TALLAHASSEE, Fla. In low doses, the general anesthetic drug ketamine works as an antidepressant, and for females the boost in mood is easier to achieve.

A Florida State University College of Medicine researcher is learning more about why this drug, used as an antidepressant for the last decade, requires a higher dosage to improve depression in males.

Mohamed Kabbaj, a professor in the Department of Biomedical Sciences at the College of Medicine, received a $1.8 million grant from the National Institute of Mental Health to support his research.

"The first purpose is to show the molecular mechanism behind the hormones estrogen and progesterone that are enhancing the effect of ketamine in females," Kabbaj said. "The other purpose of the grant is to determine whether males will respond to estrogen and progesterone in addition to ketamine administered at a low dose."

Researchers are interested in looking for ways around giving higher doses of ketamine to males because of the drug's side effects.

"At medium and high doses, ketamine can create dissociation from one's surroundings," Kabbaj said. "It's also an addictive drug, and you cannot give it chronically."

Administering ketamine with a combination of estrogen and progesterone, which are more abundant in females, may diminish some of these side effects. Kabbaj and his team continue investigating ketamine despite its side effects because of its quick antidepressant response time.

"Ketamine is used as an antidepressant in clinics now because it takes effect acutely," Kabbaj said. "Two hours after one low dose, patients feel better. The classic antidepressants take two to three weeks to work."

This quick, low-dose effect can be a lifesaver for suicidal patients whose repeated thoughts of harming themselves make time a precious commodity. It is also used as an alternative to electroconvulsive shock therapy, which depressive patients sometimes refuse.

But Kabbaj's research has shown that gender differences must be considered.

"Even with classic antidepressants there are studies showing that men and women respond differently to different classes of antidepressant drugs," Kabbaj said. "Their brains are different, so we need to find out if there are treatments that work better in women and treatments that work better in men."

Kabbaj wants to know whether striking the right balance between ketamine, progesterone and estrogen in both genders will allow for safer use of ketamine as an ongoing treatment for depression, so that it can treat those in need of immediate relief from depression without the secondary effects.


'/>"/>

Contact: Julie Jordan
julie.jordan@med.fsu.edu
850-645-9699
Florida State University
Source:Eurekalert

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Stress contributes to cognitive declines in women with breast cancer, researcher says
9. Researchers Map Brain Regions Linked to Intelligence
10. Researchers ID Genes That May Determine Mental Illness
11. Researchers Develop Blood Test for Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
Breaking Medicine Technology: